Consun Pharmaceutical Group Ltd. | Ownership
Companies that own Consun Pharmaceutical Group Ltd.
Shanghai Greenwoods Asset Management Ltd.
58,154,000
6.65%
-1,158,000
3.62%
11/03/2017
Norges Bank Investment Management
11,326,044
1.29%
-8,933,044
0%
12/31/2017
Jupiter Asset Management Ltd.
8,500,000
0.97%
8,500,000
0.02%
02/28/2018
Dimensional Fund Advisors LP
6,893,000
0.79%
1,338,000
0%
04/30/2018
UBS AG (Investment Management)
4,658,937
0.53%
-76,348,803
0%
06/04/2018
Nomura Asset Management Singapore Ltd.
2,450,269
0.28%
-570,590
0.04%
03/29/2018
UBS O'Connor LLC
2,000,000
0.23%
0
0.08%
06/04/2018
Lazard Asset Management LLC
1,949,000
0.22%
380,000
0%
08/31/2018
BNY Mellon Asset Management North America Corp.
1,660,000
0.19%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
1,535,000
0.18%
0
0%
03/31/2018
| Address |
71 Dong Peng Avenue, Eastern Section
Guangzhou Guangdong 510760
China
|
|
Employees
|
- |
| Website |
http://www.chinaconsun.com |
| Updated |
07/08/2019 |
| Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium. |
